2021
DOI: 10.4330/wjc.v13.i7.183
|View full text |Cite
|
Sign up to set email alerts
|

Current concept in the diagnosis, treatment and rehabilitation of patients with congestive heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 124 publications
0
6
0
Order By: Relevance
“…This study was approved by the Institutional Review Board (Zhongshan Hospital, Fudan University, Shanghai, China: Number B2020‐056), and conducted in a 40‐bed cardiac surgical intensive care unit (ICU). Patients were eligible to participate in the study if they met all of the following criteria 1 : clinical manifestations suggesting CHF {congestion on chest radiograph, rales on chest auscultation, clinically relevant oedema or an elevated filling pressure [either central venous pressure (CVP) ≥ 12 mmHg or pulmonary artery wedge pressure (PAWP) ≥ 15 mmHg], and an increased N terminal pro BNP [NT‐proBNP > 900 pg/mL]}, 2 , 18 , 19 weaning failure (failed spontaneous breathing test) and relied on mechanical ventilation, 3 haemodynamic monitoring via a pulmonary artery catheter, 4 decision from the attending physician to use rh‐BNP. Exclusion criteria were 1 : patients < 18 years old, 2 pregnant, 3 haemodynamic instability (norepinephrine or epinephrine ≥ 0.1 μg/kg/min), 4 unable to tolerate postural and positive end‐expiratory pressure (PEEP) changes, 5 arrythmias, and 6 severe acute kidney injury [KDIGO stage 3 20 or underwent renal replacement therapy (RRT)].…”
Section: Methodsmentioning
confidence: 99%
“…This study was approved by the Institutional Review Board (Zhongshan Hospital, Fudan University, Shanghai, China: Number B2020‐056), and conducted in a 40‐bed cardiac surgical intensive care unit (ICU). Patients were eligible to participate in the study if they met all of the following criteria 1 : clinical manifestations suggesting CHF {congestion on chest radiograph, rales on chest auscultation, clinically relevant oedema or an elevated filling pressure [either central venous pressure (CVP) ≥ 12 mmHg or pulmonary artery wedge pressure (PAWP) ≥ 15 mmHg], and an increased N terminal pro BNP [NT‐proBNP > 900 pg/mL]}, 2 , 18 , 19 weaning failure (failed spontaneous breathing test) and relied on mechanical ventilation, 3 haemodynamic monitoring via a pulmonary artery catheter, 4 decision from the attending physician to use rh‐BNP. Exclusion criteria were 1 : patients < 18 years old, 2 pregnant, 3 haemodynamic instability (norepinephrine or epinephrine ≥ 0.1 μg/kg/min), 4 unable to tolerate postural and positive end‐expiratory pressure (PEEP) changes, 5 arrythmias, and 6 severe acute kidney injury [KDIGO stage 3 20 or underwent renal replacement therapy (RRT)].…”
Section: Methodsmentioning
confidence: 99%
“…These include frail elderly patients[ 20 ], the female population, with consideration for its unique characteristics (as women are less frequently referred to CR! )[ 21 ], individuals with multiple cardiovascular comorbidities, those who have undergone transcatheter implantation or valve repair, and particularly patients with chronic heart failure (HF) (CHF)[ 7 , 22 , 23 ].…”
Section: Specialized Patient Subgroupsmentioning
confidence: 99%
“…Patients with CHF exhibit a significant degree of heterogeneity, forming an increasingly diverse population with a wide array of characteristics, including comorbidities, symptoms, clinical stability or instability, with preserved or varying degrees of reduced ejection fraction of the left ventricle. In patients with compensated HF with reduced ejection fraction, regular exercise has been shown to reduce both total hospitalizations and those related to HF, enhance exercise tolerance, and improve overall quality of life, including a reduction in depressive symptoms[ 7 , 22 ]. Taylor et al [ 7 ] aptly underscores in their recent publication that CR should be regarded as an essential, the fifth pillar in the treatment of HF patients, alongside pharmacological interventions such as beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor-neprilysin inhibitors, sodium-glucose co-transporter 2 inhibitors, and medical devices.…”
Section: Patients With Chf and Crmentioning
confidence: 99%
“…Wallentin et al performed a comparative analysis of the importance of biomarkers in chronic coronary heart disease and reported that NT-pro-BNP, troponin-T, and BNP demonstrate high importance, while AM remains less important [ 105 ]. Current guidelines recommend only BNP and/or NT-pro-BNP as markers for HF management [ 106 ]. AM is an inhibitor of tissue congestion; thus, AM and MR-pro ADM are attractive and superior biomarkers for tissue congestion, such as edema and pulmonary congestion [ 41 , 76 ].…”
Section: Plasma Levels Of Ammentioning
confidence: 99%